Asia-Pacific Vaccines Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	268 Pages	Data Bridge Market Research	February, 2023	DAABD17809891

Best Price Guarantee
Price	from $3,500
Length	268 Pages
Publisher	Data Bridge Market Research
Published Date	February, 2023
SKU	DAABD17809891

Asia-Pacific Vaccines Market - Industry Trends and Forecast to 2030

Asia-Pacific vaccines market is projected to register a CAGR of 9.4% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.

Market Segmentation:

Asia-Pacific Vaccines Market, By Composition (Combination Vaccines and Mono Vaccines), Type (Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines, Live-Attenuated Vaccines, Inactivated Vaccines, and Toxoid Vaccines), Kind (Routine Vaccine, Recommended Vaccine, and Required Vaccine), Age of Administration (Pediatric Vaccine and Adult Vaccine), Diseases (Pneumococcal Disease, Measles, Mumps & Varicella, DPT, Hepatitis, Influenza, Typhoid, Meningococcal, Rabies, Japanese Encephalitis, Yellow Fever, and Others), Route of Administration (Injectable, Oral, and Nasal), End User (Community Hospitals, Hospitals, Specialty Centres, Clinics, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Country (Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, and Rest of Asia-Pacific) Industry Trends and Forecast to 2030

Some of the major factors contributing to the growth of the vaccines market are:
• Growing immunization programs and campaigns
• Improvement in treatment
• Launch of newer vaccines

Market Players:

The key market players for Asia-Pacific vaccines market are listed below:
• Abbott
• ALK
• AstraZeneca
• BAXTER VACCINES (A Subsidiary of Baxter)
• Bharat Biotech
• Bio Farma
• Biological E Limited
• DAIICHI SANKYO COMPANY, LIMITED
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc.
• Janssen Global Services, LLC (A Subsidiary of Johnson & Johnson Services, Inc.)
• Lanzhou Biological Products Research Institute Co., Ltd.
• Merck sharp & Dohme corp. (A Subsidiary of Merck & Co., Inc.)
• Panacea Biotec Ltd
• Pfizer Inc.
• Sanofi
• Seqirus (A Subsidiary of CSL Limited)
• Serum Institute of India Pvt. Ltd.
• Takeda Pharmaceutical Company Limited

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Asia-pacific Vaccines Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Composition Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Secondary Sources; 2.11 Assumptions
3 Executive Summary
4 Premium Insight: 4.1 Pestel Model; 4.2 Porter's Five Forces; 4.3 Epidemiology; 4.4 Industrial Insights:; 4.5 Pipeline Analysis; 4.6 Asia-pacific Vaccines Market: Supply Chain Management Of Vaccines; 4.6.1 Cold Chain Storage:; 4.6.2 Process Of Logistics
5 Regulatory Framework: 5.1 Japan; 5.2 China; 5.3 South Korea; 5.4 India; 5.5 Australia; 5.6 Singapore; 5.7 Thailand; 5.8 Malaysia; 5.9 Indonesia; 5.10 Vietnam; 5.11 Philippines; 5.12 Rest Of Asia-pacific; 5.12.1 Taiwan; 5.12.2 Cambodia
6 Market Overview: 6.1 Drivers; 6.1.1 Growing Immunization Programs And Campaigns; 6.1.2 High Prevalence Of Chronic Conditions Such As Flu, Infectious And Viral Diseases; 6.1.3 Improvement In Treatment; 6.1.4 Launch Of Newer Vaccines; 6.1.5 Increasing Government Support; 6.2 Restraints; 6.2.1 Unavailability Of Registered Vaccines; 6.2.2 Difficulties Associated With The Transport And Production Of Vaccines; 6.3 Opportunities; 6.3.1 Strategic Initiatives By The Market Players; 6.3.2 Presence Of Pipeline Products; 6.3.3 Rise In Expenditure In The Healthcare Sector; 6.3.4 Increasing Awareness For Vaccination; 6.4 Challenges; 6.4.1 Side Effects Caused By Vaccines; 6.4.2 Fear Among Patients Related To Injections And Needle Sticks; 6.4.3 Product Recall
7 Asia-pacific Vaccines Market, By Composition: 7.1 Overview; 7.2 Combination Vaccines; 7.3 Mono Vaccines
8 Asia-pacific Vaccines Market, By Type: 8.1 Overview; 8.2 Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines; 8.2.1 Pneumococcal Disease; 8.2.2 Hib (Haemophilus Influenza Type B) Disease; 8.2.3 Hpv (Human Papilloma Virus); 8.2.4 Hepatitis B; 8.2.5 Meningococcal; 8.2.6 Shingles; 8.2.7 Whooping Cough; 8.2.8 Others; 8.3 Live-attenutaed Vaccines; 8.3.1 Rotavirus; 8.3.2 Measles; 8.3.3 Mumps; 8.3.4 Rubella; 8.3.5 Smallpox; 8.3.6 Yellow Fever; 8.3.7 Others; 8.4 Inactivated Vaccines; 8.4.1 Flu (Shot Only); 8.4.2 Polio (Shot Only); 8.4.3 Hepatitis A; 8.4.4 Rabies; 8.4.5 Others; 8.5 Toxoid Vaccines; 8.5.1 Diphtheria, Tetanus & Pertussis (Dtp); 8.5.2 Others
9 Asia-pacific Vaccines Market, By Kind: 9.1 Overview; 9.2 Routine Vaccines; 9.2.1 Pneumococcal Diseases; 9.3 Diptheria, Tetanus & Pertusis(Dpt); 9.3.1 Hib (Haemophilus Influenza Type B) Disease; 9.3.2 Measles; 9.3.3 Mumps; 9.3.4 Hepatitis B; 9.3.5 Rubella; 9.3.6 Polio; 9.3.7 Others; 9.4 Recommended Vaccine; 9.4.1 Typhoid Fever Vaccine; 9.5 Hepatitis A; 9.5.1 Rabies; 9.5.2 Japanese Encephalitis; 9.5.3 Tick-borne Encephalitis; 9.5.4 Cholera; 9.5.5 Others; 9.6 Required Vaccine; 9.6.1 Meningococcal; 9.7 Yellow Fever; 9.7.1 Others
10 Asia-pacific Vaccines Market, By Age Of Administration: 10.1 Overview; 10.2 Pediatric Vaccine; 10.2.1 Pneumococcal Diseases; 10.3 Measles, Mumps & Rubella; 10.3.1 Diptheria, Tetanus & Pertusis (Dpt); 10.3.2 Rotavirus; 10.3.3 Meningococcal; 10.3.4 Varicella; 10.3.5 Polio; 10.3.6 Tuberculosis; 10.3.7 Malaria; 10.3.8 Others; 10.4 Adult Vaccine; 10.4.1 Influenza; 10.5 Hpv (Human Papilloma Virus); 10.5.1 Typhoid; 10.5.2 Hepatitis B; 10.5.3 Japanese Encephalitis; 10.5.4 Yellow Fever; 10.5.5 Cancer; 10.5.6 Others
11 Asia-pacific Vaccines Market, By Diseases: 11.1 Overview; 11.2 Pneumoccocal Disease; 11.3 Measles, Mumps & Rubella; 11.4 Dpt; 11.5 Hepatitis; 11.6 Influenza; 11.7 Typhoid; 11.8 Meningococcal; 11.9 Varicella; 11.10 Rabies; 11.11 Japanese Encephalitis; 11.12 Yellow Fever; 11.13 Others
12 Asia-pacific Vaccines Market, By Route Of Administration: 12.1 Overview; 12.2 Injectable; 12.2.1 Intramuscular; 12.2.2 Subcutaneous; 12.2.3 Intradermal; 12.3 Oral; 12.4 Nasal
13 Asia-pacific Vaccines Market, By End User: 13.1 Overview; 13.2 Community Hospitals; 13.3 Hospitals; 13.4 Specialty Centers; 13.5 Clinics; 13.6 Others
14 Asia-pacific Vaccines Market, By Distribution Channel: 14.1 Overview; 14.2 Hospital Pharmacy; 14.3 Retail Pharmacy; 14.4 Online Pharmacy
15 Asia-pacific Vaccine Market: 15.1 Asia-pacific; 15.1.1 Japan; 15.1.2 China; 15.1.3 Australia; 15.1.4 India; 15.1.5 South Korea; 15.1.6 Singapore; 15.1.7 Malaysia; 15.1.8 Thailand; 15.1.9 Indonesia; 15.1.10 Philippines; 15.1.11 Vietnam; 15.1.12 Rest Of Asia Pacific
16 Asia-pacific Vaccines Market: Company Landscape: 16.1 Company Share Analysis: Asia-pacific; 16.2 Disease Share Analysis: Pfizer, Inc.; 16.3 Country Share Analysis: Pfizer, Inc.; 16.4 Disease Share Analysis: Merck Sharp & Dohme Corp. (A Subsidiary Of Merck & Co., Inc.); 16.5 Country Share Analysis: Merck Sharp & Dohme Corp. (A Subsidiary Of Merck & Co., Inc.); 16.6 Disease Share Analysis: Glaxosmithkline Plc; 16.7 Country Share Analysis: Glaxosmithkline Plc.; 16.8 Disease Share Analysis: Sanofi; 16.9 Country Share Analysis: Sanofi; 16.10 Disease Share Analysis: Serum Institute Of India Pvt. Ltd.; 16.11 Country Share Analysis: Serum Institute Of India Pvt. Ltd.
17 Swot Analysis
18 Company Profile: 18.1 Pfizer Inc.; 18.1.1 Company Snapshot; 18.1.2 Revenue Analysis; 18.1.3 Product Portfolio; 18.1.4 Recent Developments; 18.2 Merck Sharp & Dohme Corp. (A Subsidiary Of Merck & Co., Inc.); 18.2.1 Company Snapshot; 18.2.2 Revenue Analysis; 18.2.3 Company Website And Press Releases; 18.2.4 Product Portfolio; 18.2.5 Recent Developments; 18.3 Glaxosmithkline Plc.; 18.3.1 Company Snapshot; 18.3.2 Revenue Analysis; 18.3.3 Product Portfolio; 18.3.4 Recent Developments; 18.4 Sanofi; 18.4.1 Company Snapshot; 18.4.2 Revenue Analysis; 18.4.3 Product Portfolio; 18.4.4 Recent Developments; 18.5 Serum Institute Of India Pvt. Ltd.; 18.5.1 Company Snapshot; 18.5.2 Product Portfolio; 18.5.3 Recent Developments; 18.6 Abbott; 18.6.1 Company Snapshot; 18.6.2 Revenue Analysis; 18.6.3 Product Portfolio; 18.6.4 Recent Developments; 18.7 Astrazeneca (2022); 18.7.1 Company Snapshot; 18.7.2 Revenue Analysis; 18.7.3 Product Portfolio; 18.7.4 Recent Developments; 18.8 Alk; 18.8.1 Company Snapshot; 18.8.2 Revenue Analysis; 18.8.3 Product Portfolio; 18.8.4 Recent Developments; 18.9 Baxter Vaccines (A Subsidiary Of Baxter); 18.9.1 Company Snapshot; 18.9.2 Revenue Analysis; 18.9.3 Product Portfolio; 18.9.4 Recent Development; 18.10 Bharat Biotech; 18.10.1 Company Snapshot; 18.10.2 Product Portfolio; 18.10.3 Recent Developments 246
List Of Tables: Table 1 Asia-pacific Vaccines Market, Pipeline Analysis; Table 2 Recommended Temperature And Storage Length At Various Levels Of The Cold Chain.; Table 3 Logistics Process Across Different Regions.; Table 4 Laws And Regulations In Taiwan; Table 5 Vaccines Under Clinical Trial; Table 6 The Side Effects Related To The Vaccines; Table 7 Asia-pacific Vaccines Market, By Composition, 2021-2030 (Usd Million); Table 8 Asia-pacific Vaccines Market, By Type, 2021-2030 (Usd Million); Table 9 Asia-pacific Subunit, Recombinant, Polysaccharide & Conjugated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 10 Asia-pacific Live-attenuated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 11 Asia-pacific Inactivated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 12 Asia-pacific Toxoid Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 13 Asia-pacific Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 14 Asia-pacific Routine Vaccines In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 15 Asia-pacific Recommended Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 16 Asia-pacific Required Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 17 Asia-pacific Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 18 Asia-pacific Pediatric Vaccine In Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 19 Asia-pacific Adult Vaccine In Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 20 Asia-pacific Vaccines Market, By Disease, 2021-2030 (Usd Million); Table 21 Asia-pacific Vaccines Market, By Route Of Administration, 2022-2030 (Usd Million); Table 22 Asia-pacific Injectable In Vaccines Market, By Route Of Administration, 2022-2030 (Usd Million); Table 23 Asia-pacific Vaccines Market, By End User, 2022-2030 (Usd Million); Table 24 Asia-pacific Vaccines Market, By Distribution Channel, 2021-2030 (Usd Million); Table 25 Asia-pacific Knee Cartilage Repair Market, By Country, 2021-2030 (Usd Million); Table 26 Japan Vaccines Market, By Composition, 2021-2030 (Usd Million); Table 27 Japan Vaccines Market, By Type, 2021-2030 (Usd Million); Table 28 Japan Subunit, Recombinant, Polysaccharide & Conjugated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 29 Japan Live-attenuated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 30 Japan Inactivated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 31 Japan Toxoid Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 32 Japan Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 33 Japan Routine Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 34 Japan Recommended Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 35 Japan Required Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 36 Japan Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 37 Japan Pediatric Vaccine In Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 38 Japan Adult In Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 39 Japan Vaccines Market, By Disease, 2021-2030 (Usd Million); Table 40 Japan Vaccines Market, By Route Of Administration, 2021-2030 (Usd Million); Table 41 Japan Injectable In Vaccines Market, By Route Of Administration, 2021-2030 (Usd Million); Table 42 Japan Vaccines Market, By End User, 2021-2030 (Usd Million); Table 43 Japan Vaccines Market, By Distribution Channel, 2021-2030 (Usd Million); Table 44 China Vaccines Market, By Composition, 2021-2030 (Usd Million); Table 45 China Vaccines Market, By Type, 2021-2030 (Usd Million); Table 46 China Subunit, Recombinant, Polysaccharide & Conjugated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 47 China Live-attenuated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 48 China Inactivated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 49 China Toxoid Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 50 China Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 51 China Routine Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 52 China Recommended Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 53 China Required Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 54 China Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 55 China Pediatric Vaccine In Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 56 China Adult In Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 57 China Vaccines Market, By Disease, 2021-2030 (Usd Million); Table 58 China Vaccines Market, By Route Of Administration, 2021-2030 (Usd Million); Table 59 China Injectable In Vaccines Market, By Route Of Administration, 2021-2030 (Usd Million); Table 60 China Vaccines Market, By End User, 2021-2030 (Usd Million); Table 61 China Vaccines Market, By Distribution Channel, 2021-2030 (Usd Million); Table 62 Australia Vaccines Market, By Composition, 2021-2030 (Usd Million); Table 63 Australia Vaccines Market, By Type, 2021-2030 (Usd Million); Table 64 Australia Subunit, Recombinant, Polysaccharide & Conjugated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 65 Australia Live-attenuated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 66 Australia Inactivated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 67 Australia Toxoid Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 68 Australia Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 69 Australia Routine Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 70 Australia Recommended Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 71 Australia Required Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 72 Australia Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 73 Australia Pediatric Vaccine In Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 74 Australia Adult In Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 75 Australia Vaccines Market, By Disease, 2021-2030 (Usd Million); Table 76 Australia Vaccines Market, By Route Of Administration, 2021-2030 (Usd Million); Table 77 Australia Injectable In Vaccines Market, By Route Of Administration, 2021-2030 (Usd Million); Table 78 Australia Vaccines Market, By Distribution Channel, 2021-2030 (Usd Million); Table 79 India Vaccines Market, By Composition, 2021-2030 (Usd Million); Table 80 India Vaccines Market, By Type, 2021-2030 (Usd Million); Table 81 India Subunit, Recombinant, Polysaccharide & Conjugated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 82 India Live-attenuated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 83 India Inactivated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 84 India Toxoid Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 85 India Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 86 India Routine Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 87 India Recommended Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 88 India Required Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 89 India Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 90 India Pediatric Vaccine In Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 91 India Adult In Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 92 India Vaccines Market, By Disease, 2021-2030 (Usd Million); Table 93 India Vaccines Market, By Route Of Administration, 2021-2030 (Usd Million); Table 94 India Injectable In Vaccines Market, By Route Of Administration, 2021-2030 (Usd Million); Table 95 India Vaccines Market, By End User, 2021-2030 (Usd Million); Table 96 India Vaccines Market, By Distribution Channel, 2021-2030 (Usd Million); Table 97 South Korea Vaccines Market, By Composition, 2021-2030 (Usd Million); Table 98 South Korea Vaccines Market, By Type, 2021-2030 (Usd Million); Table 99 South Korea Subunit, Recombinant, Polysaccharide & Conjugated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 100 South Korea Live-attenuated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 101 South Korea Inactivated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 102 South Korea Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 103 South Korea Routine Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 104 South Korea Recommended Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 105 South Korea Required Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 106 South Korea Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 107 South Korea Pediatric Vaccine In Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 108 South Korea Adult In Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 109 South Korea Vaccines Market, By Disease, 2021-2030 (Usd Million); Table 110 South Korea Vaccines Market, By Route Of Administration, 2021-2030 (Usd Million); Table 111 South Korea Injectable In Vaccines Market, By Route Of Administration, 2021-2030 (Usd Million); Table 112 South Korea Vaccines Market, By End User, 2021-2030 (Usd Million); Table 113 South Korea Vaccines Market, By Distribution Channel, 2021-2030 (Usd Million); Table 114 Singapore Vaccines Market, By Composition, 2021-2030 (Usd Million); Table 115 Singapore Subunit, Recombinant, Polysaccharide & Conjugated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 116 Singapore Live-attenuated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 117 Singapore Inactivated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 118 Singapore Toxoid Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 119 Singapore Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 120 Singapore Routine Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 121 Singapore Recommended Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 122 Singapore Required Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 123 Singapore Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 124 Singapore Pediatric Vaccine In Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 125 Singapore Adult In Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 126 Singapore Vaccines Market, By Disease, 2021-2030 (Usd Million); Table 127 Singapore Vaccines Market, By Route Of Administration, 2021-2030 (Usd Million); Table 128 Singapore Injectable In Vaccines Market, By Route Of Administration, 2021-2030 (Usd Million); Table 129 Singapore Vaccines Market, By End User, 2021-2030 (Usd Million); Table 130 Singapore Vaccines Market, By Distribution Channel, 2021-2030 (Usd Million); Table 131 Malaysia Vaccines Market, By Composition, 2021-2030 (Usd Million); Table 132 Malaysia Vaccines Market, By Type, 2021-2030 (Usd Million); Table 133 Malaysia Subunit, Recombinant, Polysaccharide & Conjugated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 134 Malaysia Live-attenuated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 135 Malaysia Inactivated Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 136 Malaysia Toxoid Vaccines In Vaccines Market, By Type, 2021-2030 (Usd Million); Table 137 Malaysia Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 138 Malaysia Routine Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 139 Malaysia Recommended Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 140 Malaysia Required Vaccine In Vaccines Market, By Kind, 2021-2030 (Usd Million); Table 141 Malaysia Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 142 Malaysia Pediatric Vaccine In Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 143 Malaysia Adult In Vaccines Market, By Age Of Administration, 2021-2030 (Usd Million); Table 144 Malaysia Vaccines Market, By Disease, 2021-2030 (Usd Million); Table 145 Malaysia Vaccines Market, By Route Of Administration, 2021-2030 (Usd Million); Table 146 Malaysia Injectable In Vaccines Market, By Route Of Administration, 2021-2030 (Usd Million); Table 147 Malaysia Vaccines Market, By End User, 2021-2030 (Usd Million); Table 148 Malaysia Vaccines Market, By Distribution Channel, 2021-2030 (Usd Million); Table 149 Thailand Vaccines Market, By Composition, 2021-2030 (Usd Million)
List Of Figures: Figure 1 Asia-pacific Vaccines Market: Segmentation; Figure 2 Asia-pacific Vaccines Market: Data Triangulation; Figure 3 Asia-pacific Vaccines Market: Droc Analysis; Figure 4 Asia-pacific Vaccines Market: Asia-pacific Vs Country Market Analysis; Figure 5 Asia-pacific Vaccines Market: Company Research Analysis; Figure 6 Asia-pacific Vaccines Market: Multivariate Modelling; Figure 7 Asia-pacific Vaccines Market: Interview Demographics; Figure 8 Asia-pacific Vaccines Market: Dbmr Market Position Grid; Figure 9 Asia-pacific Vaccines Market: Segmentation; Figure 10 Growing Immunization Programs And Campaigns And The High Prevalence Of Chronic Conditions Such As Flu And Bacterial Infectious Diseases Are Driving The Asia-pacific Vaccines Market In The Forecast Period Of 2023 To 2030; Figure 11 The Combination Vaccines Segment Is Expected To Account For The Largest Share Of The Asia-pacific Vaccines Market In 2023 & 2030; Figure 12 Fda Regulatory Review Process Of Vaccines; Figure 13 Process Of Special Approval On Vaccines During The 2019 H1n1pdm Pandemic; Figure 14 Regulation Overview For Therapeutics In Singapore; Figure 15 Drivers, Restraints, Opportunities And Challenges Of The Asia-pacific Vaccines Market; Figure 16 Asia-pacific Vaccines Market: By Composition, 2022; Figure 17 Asia-pacific Vaccines Market: By Composition, 2023-2030 (Usd Million); Figure 18 Asia-pacific Vaccines Market: By Composition, Cagr (2023-2030); Figure 19 Asia-pacific Vaccines Market: By Composition, Lifeline Curve; Figure 20 Asia-pacific Vaccines Market: By Type, 2022; Figure 21 Asia-pacific Vaccines Market: By Type, 2023-2030 (Usd Million); Figure 22 Asia-pacific Vaccines Market: By Type, Cagr (2023-2030); Figure 23 Asia-pacific Vaccines Market: By Type, Lifeline Curve; Figure 24 Asia-pacific Vaccines Market: By Kind, 2022; Figure 25 Asia-pacific Vaccines Market: By Kind, 2023-2030 (Usd Million); Figure 26 Asia-pacific Vaccines Market: By Kind, Cagr (2023-2030); Figure 27 Asia-pacific Vaccines Market: By Kind, Lifeline Curve; Figure 28 Asia-pacific Vaccines Market: By Age Of Administration, 2022; Figure 29 Asia-pacific Vaccines Market: By Age Of Administration, 2023-2030 (Usd Million); Figure 30 Asia-pacific Vaccines Market: By Age Of Administration, Cagr (2023-2030); Figure 31 Asia-pacific Vaccines Market: By Age Of Administration, Lifeline Curve; Figure 32 Asia-pacific Vaccines Market: By Diseases, 2022; Figure 33 Asia-pacific Vaccines Market: By Diseases, 2023-2030 (Usd Million); Figure 34 Asia-pacific Vaccines Market: By Diseases, Cagr (2023-2030); Figure 35 Asia-pacific Vaccines Market: By Diseases, Lifeline Curve; Figure 36 Asia-pacific Vaccines Market: By Route Of Administration, 2022; Figure 37 Asia-pacific Vaccines Market: By Route Of Administration, 2023-2030 (Usd Million); Figure 38 Asia-pacific Vaccines Market: By Route Of Administration, Cagr (2023-2030); Figure 39 Asia-pacific Vaccines Market: By Route Of Administration, Lifeline Curve; Figure 40 Asia-pacific Vaccines Market: By End User, 2022; Figure 41 Asia-pacific Vaccines Market: By End User, 2023-2030 (Usd Million); Figure 42 Asia-pacific Vaccines Market: By End User, Cagr (2023-2030); Figure 43 Asia-pacific Vaccines Market: By End User, Lifeline Curve; Figure 44 Asia-pacific Vaccines Market: By Distribution Channel, 2022; Figure 45 Asia-pacific Vaccines Market: By Distribution Channel, 2023-2030 (Usd Million); Figure 46 Asia-pacific Vaccines Market: By Distribution Channel, Cagr (2023-2030); Figure 47 Asia-pacific Vaccines Market: By Distribution Channel, Lifeline Curve; Figure 48 Asia-pacific Vaccine Market: Snapshot (2022); Figure 49 Asia-pacific Vaccine Market: By Country (2022); Figure 50 Asia-pacific Vaccine Market: By Country (2023 & 2030); Figure 51 Asia-pacific Vaccine Market: By Country (2022 & 2030); Figure 52 Asia-pacific Vaccine Market: By Composition (2023-2030); Figure 53 Asia-pacific Vaccines Market: Company Share 2022 (%); Figure 54 Pfizer, Inc., Asia-pacific Vaccines Market: Disease Share 2022 (%); Figure 55 Pfizer, Inc., Asia-pacific Vaccines Market: Country Share 2022 (%); Figure 56 Merck Sharp & Dohme Corp. (A Subsidiary Of Merck & Co., Inc.) Asia-pacific Vaccines Market: Disease Share 2022 (%); Figure 57 Merck Sharp & Dohme Corp. (A Subsidiary Of Merck & Co., Inc.) Asia-pacific Vaccines Market: Country Share 2022 (%); Figure 58 Glaxosmithkline Plc, Asia-pacific Vaccines Market: Disease Share 2022 (%); Figure 59 Glaxosmithkline Plc, Asia-pacific Vaccines Market: Company Share 2022 (%); Figure 60 Sanofi, Asia-pacific Vaccines Market: Disease Share 2022 (%); Figure 61 Sanofi Asia-pacific Vaccines Market: Country Share 2022 (%); Figure 62 Serum Institute Of India Pvt. Ltd., Asia-pacific Vaccines Market: Disease Share 2022 (%); Figure 63 Serum Institute Of India Pvt. Ltd. Asia-pacific Vaccines Market: Country Share 2022 (%) 222